---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-26-053378"
form_type: "8-K"
ticker: "CNTX"
cik: "0001842952"
company_name: "Context Therapeutics Inc."
filed_at: "2026-08-05T20:16:31+00:00"
generated_at: "2026-08-05T20:18:46.634882+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "low"
source: SEC EDGAR
---

# Context Therapeutics updates corporate presentation for investor meetings; no specific new data disclosed

## Summary
- Filed an 8-K on August 5, 2026, to furnish an updated corporate presentation as Exhibit 99.1.
- Presentation titled 'Advancing T Cell Engagers for Solid Tumors' but full content not provided in filing.
- No financial results, clinical data, or material events announced in the 8-K body.
- Routine FD disclosure; presentation used for meetings with investors and analysts.

## SEC filing metadata
- accession: 0001628280-26-053378
- form_type: 8-K
- ticker: CNTX
- cik: 0001842952
- company_name: Context Therapeutics Inc.
- filed_at: 2026-08-05T20:16:31+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1842952/000162828026053378/0001628280-26-053378-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1842952/000162828026053378/cntx-20260805.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-26-053378
- JSON: https://secwatch.observer/filing/0001628280-26-053378.json
- Plain text: https://secwatch.observer/filing/0001628280-26-053378.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.